• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性重型乙型肝炎预后指标的判别函数及死亡概率

Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B.

作者信息

Ke Wei-Min, Ye Yi-Nong, Huang Shi

机构信息

Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-Sen University, Shipai, Guangzhou, Guangdong Province 510630, P R China.

出版信息

J Gastroenterol. 2003;38(9):861-4. doi: 10.1007/s00535-003-1162-3.

DOI:10.1007/s00535-003-1162-3
PMID:14564632
Abstract

BACKGROUND

We aimed to determine a discriminant function for prognosis in chronic severe hepatitis B (CSHB), by discriminant analysis of prognostic indexes and probability of death.

METHODS

In 205 patients with chronic severe hepatitis B (101 patients in the survival group and 104 patients in the death group), we carried out discriminant analysis of serum total bilirubin, prothrombin activity, white blood cells, creatinine, maximum depth of ascites, hepatic encephalopathy, singultus, and digestive tract hemorrhage.

RESULTS

The discriminant function was V=0.00043 x total bilirubin (microM) - 0.025 x prothrombin activity (%) + 0.056 x white blood cells (10(9)/l) + 0.00284 x creatinine (microM) + 0.0014 x maximum depth of ascites (mm) + 0.724 x hepatic encephalopathy score + 0.078 x singultus score + 0.457 x digestive tract hemorrhage score - 2.488. The correctness of the function for predicting death in the death group was 92.3%, and that for predicting survival in the survival group was 96.0%. When the V values were -infinity, -4.595, -2.197, -1.386, -0.405, 0.405, 1.386, 2.197, 2.944, 4.595, and infinity, a posterior probabilities of death were 0%, 5%, 10%, 20%, 40%, 60%, 80%, 90%, 95%, 99%, and 100%, respectively.

CONCLUSIONS

The discriminant function is an objective, convenient, and practical method to assess the prognosis of chronic severe hepatitis B.

摘要

背景

我们旨在通过对慢性重型乙型肝炎(CSHB)预后指标和死亡概率进行判别分析,确定一种用于慢性重型乙型肝炎预后的判别函数。

方法

对205例慢性重型乙型肝炎患者(存活组101例,死亡组104例)的血清总胆红素、凝血酶原活动度、白细胞、肌酐、腹水最大深度、肝性脑病、呃逆及消化道出血情况进行判别分析。

结果

判别函数为V = 0.00043×总胆红素(微摩尔) - 0.025×凝血酶原活动度(%) + 0.056×白细胞(10⁹/L) + 0.00284×肌酐(微摩尔) + 0.0014×腹水最大深度(毫米) + 0.724×肝性脑病评分 + 0.078×呃逆评分 + 0.457×消化道出血评分 - 2.488。该函数对死亡组死亡预测的正确率为92.3%,对存活组生存预测的正确率为96.0%。当V值为负无穷、-4.595、-2.197、-1.386、-0.405、0.405、1.386、2.197、2.944、4.595及正无穷时,死亡的后验概率分别为0%、5%、10%、20%、40%、60%、80%、90%、95%、99%及100%。

结论

该判别函数是评估慢性重型乙型肝炎预后的一种客观、便捷且实用的方法。

相似文献

1
Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B.慢性重型乙型肝炎预后指标的判别函数及死亡概率
J Gastroenterol. 2003;38(9):861-4. doi: 10.1007/s00535-003-1162-3.
2
[Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].[应用终末期肝病模型分析慢性重型乙型肝炎患者的短期预后]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jul;19(7):416-8.
3
Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.终末期肝病-钠模型可预测慢性重型乙型肝炎患者的预后。
Chin Med J (Engl). 2008 Oct 20;121(20):2065-9.
4
Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.
J Gastroenterol. 2002;37(8):626-32. doi: 10.1007/s005350200099.
5
Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.台湾接受拉米夫定治疗的慢性乙型肝炎相关失代偿患者的早期死亡率:终末期肝病模型和指数评分系统作为预后预测指标的评估
Clin Ther. 2006 Dec;28(12):2081-92. doi: 10.1016/j.clinthera.2006.12.016.
6
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.慢性重型肝炎的预后因素及预后模型的构建
Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):40-4.
7
A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation.
Hepatology. 1994 May;19(5):1065-71.
8
[A simple scoring system to evaluate the severity of acute-on-chronic liver failure in hepatitis B].[一种评估乙型肝炎慢性肝衰竭急性发作严重程度的简易评分系统]
Zhonghua Yi Xue Za Zhi. 2009 Dec 22;89(47):3353-5.
9
[Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].[Child-Turcotte-Pugh评分及终末期肝病模型对预测慢性重型肝炎预后的临床价值]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jul;19(7):412-5.
10
[Analysis of prognostic factors of and to establish a predictive model for patients with chronic severe hepatitis].
Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):730-3.

引用本文的文献

1
Pitfalls of the concordance index for survival outcomes.生存结局的吻合指数的陷阱。
Stat Med. 2023 Jun 15;42(13):2179-2190. doi: 10.1002/sim.9717. Epub 2023 Mar 28.
2
Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey.中国北方3916例肝衰竭患者病因的变化:一项为期10年的调查。
Hepatol Int. 2013 Jun;7(2):714-20. doi: 10.1007/s12072-013-9424-5. Epub 2013 Feb 7.
3
Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model.
恩替卡韦治疗可预防乙型肝炎病毒相关慢加急性肝衰竭的疾病进展:建立一种新型逻辑回归模型。
Hepatol Int. 2012 Oct;6(4):735-43. doi: 10.1007/s12072-012-9344-9. Epub 2012 Feb 25.
4
Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure.将血清胱抑素C与总胆红素相结合可改善乙肝相关慢加急性肝衰竭患者短期死亡率的预测。
PLoS One. 2015 Jan 28;10(1):e0116968. doi: 10.1371/journal.pone.0116968. eCollection 2015.
5
Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.HBV相关慢加急性肝衰竭期间循环中Foxp3(+)调节性T细胞和产生白细胞介素-17的辅助性T细胞的变化
World J Gastroenterol. 2014 Jul 14;20(26):8558-71. doi: 10.3748/wjg.v20.i26.8558.
6
Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B.血小板活化因子乙酰水解酶升高在乙型肝炎患者中的临床应用
Lipids Health Dis. 2014 Jun 28;13:105. doi: 10.1186/1476-511X-13-105.
7
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.胱抑素 C 是预测急性肝衰竭患者急性肾损伤的生物标志物。
World J Gastroenterol. 2013 Dec 28;19(48):9432-8. doi: 10.3748/wjg.v19.i48.9432.
8
Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice.联合腺病毒介导的针对 mfgl2、mFas 和 mTNFR1 的人工 microRNAs 可预防小鼠暴发性肝衰竭。
PLoS One. 2013 Nov 26;8(11):e82330. doi: 10.1371/journal.pone.0082330. eCollection 2013.
9
CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure.CD34+ 造血干细胞动员,与 HBV 相关慢加急性肝衰竭患者体内多种细胞因子升高呈平行关系。
Dig Dis Sci. 2013 Feb;58(2):448-57. doi: 10.1007/s10620-012-2458-z. Epub 2012 Oct 25.
10
Correlation between plasma amino acid profiles and the various stages of hepatitis B infection.血浆氨基酸谱与乙型肝炎感染各阶段的相关性。
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):2045-52. doi: 10.1007/s10096-011-1538-x.